Olaf Müller is an expert in Infectiology at University Hospital Heidelberg (Germany). As of July 2026, ScienceLeadR ranks Olaf Müller in the top 1% of experts worldwide for Mosquito-Borne Diseases. Olaf Müller has authored 231 publications, the most recent in 2026, and is an investigator in 8 clinical trials. SLR score: 744 (community average: 125). How the SLR is computed.

LeadR Profile

744 ScienceLeadR Reputation 744
Network Map

Infectiology

Subspecialties: Public Health - Biostatistics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026

Source: PubMed

Heidelberg University (Germany)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 231

Citations

Citations: 13 722 1st author: 53 Last author: 63 Unique author: 14


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Healthcare utilization patterns and diagnostic delays among international migrant workers with imported malaria in China: a retrospective cohort analysis.
PMID 42399742 — malaria, diagnosis
Malar J20260
Divergent urban-rural drivers of malaria vector ecology: a 6-year One Health longitudinal study in China.
PMID 42298720 — malaria, ecology, longitudinal studies, climate, parasites
Parasit Vectors20260
Building a tool to assess malaria surveillance and response capacity in malaria post-elimination contexts: a modified and dual-weighted Delphi approach.
PMID 41449479 — malaria, diagnosis
Infect Dis Poverty20250
Achievements and Obstacles in the Late Phase of the Global Polio Eradication Initiative.
PMID 40407715 — achievement, poliomyelitis, vaccines, vaccination, viruses, poliovirus, vaccination coverage
Dtsch Arztebl Int20250
Environmental, socioeconomic, and sociocultural drivers of monkeypox transmission in the Democratic Republic of the Congo: a One Health perspective.
PMID 39920861 — incidence, mpox (monkeypox), zoonoses, centers for disease control and prevention, u.s., risk factors, environment, epidemics, forests
Infect Dis Poverty20252

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 2 5
Phase 4 2
Phase 3 1

By status:

Completed 7
Withdrawn 1

By type:

Interventional 8

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map